Related Experiment Video
Updated: Jun 27, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Trefoil Factor 3 as a Biomarker for Peripheral Artery Disease
Ben Li1,2,3,4, Hamzah Khan1,2,3, Farah Shaikh1
1Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, University of Toronto, 30 Bond Street, Toronto, ON M5B 1W8, Canada.
Trefoil factor 3 (TFF3) shows strong association with peripheral artery disease (PAD). Integrating TFF3 with clinical data creates a predictive model for PAD diagnosis and major adverse limb event (MALE) risk.
Area of Science:
- Biomarkers in cardiovascular research
- Vascular disease diagnostics
- Predictive modeling in medicine
Background:
- Trefoil factor 3 (TFF3) is linked to cardiovascular disease, but its role in peripheral artery disease (PAD) is understudied.
- This study investigated TFF3 as a potential biomarker for PAD and its associated risks.
Purpose of the Study:
- To assess the association of circulating TFF3 with PAD presence.
- To develop predictive models for PAD diagnosis and major adverse limb events (MALE) risk using TFF3 and clinical data.
Main Methods:
- Prospective study of 476 individuals (312 PAD patients, 164 controls).
- Quantified plasma TFF3, OSM, and BDNF; monitored MALE over two years.
- Developed predictive models using a random forest algorithm with TFF3 and clinical variables, validated by AUROC.
Main Results:
- TFF3 concentrations were significantly higher in PAD patients compared to controls (p < 0.001).
- Predictive models showed strong performance for PAD detection (AUROC 0.79) and 2-year MALE risk estimation (AUROC 0.85).
- TFF3 emerged as the most influential predictor for MALE, surpassing age and smoking history.
Conclusions:
- Plasma TFF3 combined with clinical characteristics effectively predicts PAD diagnosis and 2-year MALE risk.
- This model can improve risk stratification, enabling earlier intervention and targeted treatment for PAD patients.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
